Tvardi Therapeutics

IN THE PRESS

Business

Tvardi Therapeutics Appoints Sujal Shah as Chairman and Adds Shaheen Wirk to the Board of Directors

March 26, 2024

·

2 min read

Lone Star Bio

Tvardi Therapeutics to Participate at the Cowen 44th Annual Health Care Conference

March 1, 2024

·

1 min read

Lone Star Bio

Tvardi Therapeutics Announces Presentation of REVERT LIVER CANCER Phase 2 Clinical Trial Using TTI-101, A Novel STAT3 Inhibitor, at 2024 ASCO Gastrointestinal Cancers Symposium

January 18, 2024

·

2 min read

Lone Star Bio

Tvardi Therapeutics to Present at the 35th Annual Piper Sandler Healthcare Conference

November 21, 2023

·

1 min read

JOBS